Researchers at Durham University, in collaboration with international partners, have developed a robotic system that allows ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...

Third-quarter GAAP diluted EPS of $0.94 and adjusted diluted EPS of $1.21, which excludes specified items. Abbott maintains its full-year 2024 organic sales growth guidance range ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...